| Lyn tyrosine kinase | Clinical trial target | Tyrosine-protein kinase Lyn;Lck/Yes-related novel protein tyrosine kinase;V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;LYN | Cancer | JNJ-26483327;Bafetinib;Bafetinib;Bafetinib | JNJ-26483327;Bafetinib;NG-25;compound 23 | |